Literature DB >> 26916230

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Julia M L Brotherton1,2, Mark Jit3,4, Patti E Gravitt5, Marc Brisson6, Aimée R Kreimer7, Sara I Pai8, Carole Fakhry9, Joseph Monsonego10, Silvia Franceschi11.   

Abstract

This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.
© 2016 UICC.

Entities:  

Keywords:  HPV; cervical cancer; oropharyngeal cancer; vaccine

Mesh：

Substances：

Year:  2016        PMID： 26916230      PMCID： PMC7388730          DOI： 10.1002/ijc.30063

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


  104 in total

1.  Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.

Authors:  Joshua W Wang; Subhashini Jagu; Wai-Hong Wu; Raphael P Viscidi; Anne Macgregor-Das; Jessica M Fogel; Kihyuck Kwak; Sai Daayana; Henry Kitchener; Peter L Stern; Patti E Gravitt; Cornelia L Trimble; Richard B S Roden
Journal:  Clin Vaccine Immunol       Date:  2015-05-13

2.  Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States.

Authors:  Marc Brisson; Jean-François Laprise; Harrell W Chesson; Mélanie Drolet; Talía Malagón; Marie-Claude Boily; Lauri E Markowitz
Journal:  J Natl Cancer Inst       Date:  2015-10-04       Impact factor: 13.506

Review 3.  An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.

Authors:  Michelle Vichnin; Paolo Bonanni; Nicola P Klein; Suzanne M Garland; Stan L Block; Susanne K Kjaer; Heather L Sings; Gonzalo Perez; Richard M Haupt; Alfred J Saah; Fabio Lievano; Christine Velicer; Rosybel Drury; Barbara J Kuter
Journal:  Pediatr Infect Dis J       Date:  2015-09       Impact factor: 2.129

4.  Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.

Authors:  Susanne K Kjær; Kirsten Frederiksen; Christian Munk; Thomas Iftner
Journal:  J Natl Cancer Inst       Date:  2010-09-14       Impact factor: 13.506

5.  Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.

Authors:  Peng Guan; Rebecca Howell-Jones; Ni Li; Laia Bruni; Silvia de Sanjosé; Silvia Franceschi; Gary M Clifford
Journal:  Int J Cancer       Date:  2012-03-20       Impact factor: 7.396

6.  Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives.

Authors:  Lars Toft; Martin Tolstrup; Merete Storgaard; Lars Ostergaard; Ole S Søgaard
Journal:  Sex Health       Date:  2014-12       Impact factor: 2.706

7.  Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States.

Authors:  Harrell W Chesson; Donatus U Ekwueme; Mona Saraiya; Meg Watson; Douglas R Lowy; Lauri E Markowitz
Journal:  Vaccine       Date:  2012-08-04       Impact factor: 3.641

8.  Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.

Authors:  Sun M Ahn; Jason Y K Chan; Zhe Zhang; Hao Wang; Zubair Khan; Justin A Bishop; William Westra; Wayne M Koch; Joseph A Califano
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-09       Impact factor: 6.223

Review 9.  New technologies and procedures for cervical cancer screening.

Authors:  Jack Cuzick; Christine Bergeron; Magnus von Knebel Doeberitz; Patti Gravitt; Jose Jeronimo; Attila T Lorincz; Chris J L M Meijer; Rengaswamy Sankaranarayanan; Peter J F Snijders; Anne Szarewski
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

10.  Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.

Authors:  Shannon Stokley; Jenny Jeyarajah; David Yankey; Maria Cano; Julianne Gee; Jill Roark; Robinette C Curtis; Lauri Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-25       Impact factor: 17.586
View more
  6 in total

1.  [Epidemiology, prevention and early detection of cervical cancer].

Authors:  Nicolas Wentzensen
Journal:  Onkologe (Berl)       Date:  2016-08-04       Impact factor: 0.234

2.  High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.

Authors:  Zizipho Z A Mbulawa; Cari van Schalkwyk; Nai-Chung Hu; Tracy L Meiring; Shaun Barnabas; Smritee Dabee; Heather Jaspan; Jean-Mari Kriek; Shameem Z Jaumdally; Etienne Muller; Linda-Gail Bekker; David A Lewis; Janan Dietrich; Glenda Gray; Jo-Ann S Passmore; Anna-Lise Williamson
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

3.  Purification and Characterization of Antibodies in Single-Chain Format against the E6 Oncoprotein of Human Papillomavirus Type 16.

Authors:  F Verachi; Z Percario; P Di Bonito; E Affabris; C Amici; L Accardi
Journal:  Biomed Res Int       Date:  2018-05-20       Impact factor: 3.411

4.  Socio-demographic correlates of cervical cancer risk factor knowledge among screening non-participants in Great Britain.

Authors:  Mairead Ryan; Laura Marlow; Jo Waller
Journal:  Prev Med       Date:  2019-05-11       Impact factor: 4.018

Review 5.  Human papillomavirus and gastrointestinal cancer: A review.

Authors:  Dania Bucchi; Fabrizio Stracci; Nicola Buonora; Giuseppe Masanotti
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

6.  The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.

Authors:  Suzette M Matthijsse; Steffie K Naber; Jan A C Hontelez; Roel Bakker; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar; Inge M C M de Kok; Harry J de Koning; Joost van Rosmalen; Sake J de Vlas
Journal:  PLoS One       Date:  2018-09-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.